Clinical and paraclinical characteristics of patients with abnormal HPV tests and cervical cytology tests at Hanoi Obstetrics and Gynecology Hospital

  • Nguyễn Duy Ánh Bệnh viện Phụ sản Hà Nội
  • Trần Thị Ngọc Linh Bệnh viện Phụ sản Hà Nội

Main Article Content

Keywords

HPV, cervical cytology, HSIL, LSIL, gynecological examination

Abstract

Objective: To describe the clinical and paraclinical characteristics of patients with abnormal HPV tests and cervical cytology tests at Hanoi Obstetrics and Gynecology Hospital. Subject and method: This study recruited 1700 women already having sexual intercourse. Participants had inteviews, gynecological examination and cervical cancer screenings including Human Papilloma virus test and cervical cytology test at Hanoi Obstetrics and Gynecology Hospital from 10/2016 to 07/2017. Result: 199 patients had abnormal HPV tests and cervical cytology tests (12%). Of these patients, 33.67% had normal gynecological examination, 30.66% had vaginitis or vulvitis, 28.14% had cervical ectropion, 5.03% had cervical polyps, 5.03% had vaginal warts, 1.01% had cervical ulcer. About cervical cytology test, normal specimens accounted for 30.15%, LSIL was 63.23%, HSIL was 5.53%, carcinoma was 1.01%. HPV test resulted in negative at 47.24%, type 16 at 9.55%, type 18 at 2.01%, 12 other types at 3.67% and multitype infection at 6.54%. Conclusion: Women having abnormal HPV test and cervical cytology test at Hanoi Obstetrics and Gynecology Hospital clinically had vaginitis or vulvitis, cervical ectropion, vaginal warts, cervical polyps and cervical ulcer. Cervical cytology test showed LSIL, HSIL and carcinoma. HPV test resulted in type 16, 18, 12 other types and multitype.

Article Details

References

Nguyễn Ngọc Khuyên (2008) Tầm soát ung thư cổ tử cung trong cộng đồng dân cư huyện Chợ Mới- An Giang. Tạp chí Y học thành phố Hồ Chí Minh, 12(4).
2. Trần Thị Vân, Chu Văn Đức (2013) Đánh giá tỉ lệ viêm âm đạo cổ tử cung và ung thư cổ tử cung ở phụ nữ tại huyện Thanh Thuỷ - Phú Thọ. Tạp chí Y học thực hành, 3, tr. 65-67.
3. Phạm Thị Thanh Yên và cộng sự (2016) Tỉ lệ nhiễm HPV ở phụ nữ đến khám tại Bệnh viện Phụ sản Trung ương. Tạp chí Phụ sản, 14 (01), tr. 125-128.
4. Phoolcharoen N, Kantathavorn N, Sricharunrat T, Saeloo S, Krongthong W (2017) A population-based study of cervical cytology findings and human papillomavirus infection in a suburban area of Thailand. Gynocologic oncology report 21: 73-77.
5. Xiang J, Han L, Fan Y, Feng B, Wu H, Hu C, Qi M, Wang H, Liu Q, Liu Y (2021) Prevalence and genotype distribution of human papillomavirus among attendees at a sexually transmitted diseases clinic in Urban Tianjin, China. International Journal of General Medicine 14: 1983-1990.
6. Ward JM, Schmalenberg K, Antonishyn NA, Hambleton IR, Blackman EL, Levett PN, Gittens-St Hilaire MV (2017) Human papillomavirus genotype distribution in cervical samples among vaccine naïve Barbados women [pubmed].
7. Zhang C, Zhang C, Huang J, Wu Z, Mei X, Shi W (2017) Prevalence and genotype distribution of human papillomavirus among females in the suburb of Shanghai, China [pubmed].
8. Dursun P, Senger SS, Arslan H, Kuşçu E, Ayhan A (2009) HPV prevalence and types among Turkish women at a gynecology out patient unit. BMC Infect Dis 9: 191.
9. Vorsters A, Cornelissen T, Leuridan E et al (2016) Prevalence of high-risk human papillomavirus and abnormal pap smears in female sex workers compared to the general population in Antwerp, Belgium. BMC Public Health 16: 447.
10. Zur Hausen H (2011) Vaccines: What remains to be done?. Vaccine 10(11): 1505-1507.